BSECompany Update5 Nov 2026 · 5 Nov 2026, 05:03 pm

Detailed disclosure is attached.

Gujarat Terce Laboratories Ltd · 524314

✦ AI SummaryExpansion

Gujarat Terce Laboratories Ltd has entered into an agreement to purchase a corporate office premises 'Swati18' located in Ahmedabad. The company has disclosed the details of the agreement as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gujarat Terce Laboratories Ltd - 524314 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended From Time To Time (Listing Regulations)

Attachments (1)

📄

a34670c0-c913-4ad3-9edc-64eb1450dc9d.pdf

pdf

Download →
View document text
5 November 2026 BSE Limited (Security Code: 524314) Phiroze Jeejeeboy Towers, Dalal Street, Fort, Mumbai- 400 001. Dear Sir/Madam, Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time (Listing Regulations) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Company has entered into an agreement(s) for purchase of Corporate office premises “Swati18” located beside Palladium Mall, S.G. Highway, Thaltej, Ahmedabad. Further, the requisite details as prescribed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III thereto and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed herewith as Annexure- This intimation is also uploaded on the Company’s website and can be accessed at the weblink: https://www.gujaratterce.in/announcements/ For Gujarat Terce Laboratories Limited Ms. Ashka Solanki Company Secretary Enclosures: As above Annexure-I Details under amended Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 Sr. No. Particulars Details 1. Name of parties with whom the agreement is Swatisandhya Procon LLP entered 2. Purpose of entering into the agreement Purchase of immovable property (Corporate Office premises) 3. Shareholding, if any, in the entity with whom the Nil agreement is executed 4. Significant terms of the agreement (in brief) special Purchase of immovable property of 2012.20 rights like right to appoint directors, first right to sq.ft. at Rs. 3.23 crores (exclusive of applicable share subscription in case of issuance of shares, taxes, stamp duty, registration fees and other right to restrict any change in capital structure etc statutory or incidental charges payable under the agreement to sell) 5. Whether, the said parties are related to No promoter/promoter group/ group companies in any manner. If yes, nature of relationship 6. Whether the transaction would fall within related No party transactions? If yes, whether the same is done at “arm’s length” 7. In case of issuance of shares to the parties, details No of issue price, class of shares issued 8. Any other disclosures related to such agreements, N.A. viz., details of nominee on the board of directors of the listed entity, potential conflict of interest arising out of such agreements, etc 9. In case of termination or amendment of N.A. agreement, listed entity shall disclose additional details to the stock exchange(s): a) name of parties to the agreement; b) nature of the agreement; c) date of execution of the agreement; d) details of amendment and impact thereof or reasons of termination and impact thereof